AC
FOLD

Allstate Corporation’s Amicus Therapeutics FOLD Stock Holding History

Allstate Corporation’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$654K Buy
+45,222
New +$648K 0.01% 942
2022
Q1 		– Sell
-30,006
Closed -$347K – 653
2021
Q4 		$347K Sell
30,006
-715
-2% -$7.97K 0.01% 709
2021
Q3 		$293K Buy
30,721
+12,295
+67% +$126K 0.01% 639
2021
Q2 		$178K Sell
18,426
-991
-5% -$9.67K 0.01% 713
2021
Q1 		$192K Buy
19,417
+4,033
+26% +$62.4K 0.01% 718
2020
Q4 		$355K Buy
+15,384
New +$315K 0.01% 586

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Allstate Corporation's FOLD Position: Q1 2026 in Review

Allstate Corporation opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 45,222 shares worth $654K. The stake represents 0.01% of the portfolio and ranks #942 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in FOLD as recently as Q4 2021.

Allstate Corporation first reported a position in FOLD in Q4 2020 and has held it in 6 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Allstate Corporation held 45,222 shares of Amicus Therapeutics worth $654K as of Q1 2026.
  • Amicus Therapeutics was a new Allstate Corporation position in Q1 2026.
  • Amicus Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #942 holding.
  • Allstate Corporation first reported a position in Amicus Therapeutics in Q4 2020 and has held it in 6 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.